Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Proven pulmonary aspergillosis in a COVID-19 patient: A case report.
Khodavaisy S, Khajavirad N, Hashemi SJ, Izadi A, Dehghan Manshadi SA, Abdollahi A, Aliramezani A, Sasani E, Abdorahimi M, Kiyaeie RS, Khosravany Z, Getso MI, Salehi M. Khodavaisy S, et al. Among authors: khajavirad n. Curr Med Mycol. 2021 Jun;7(2):39-42. doi: 10.18502/cmm.7.2.7031. Curr Med Mycol. 2021. PMID: 35028484 Free PMC article.
Oropharyngeal candidiasis in hospitalised COVID-19 patients from Iran: Species identification and antifungal susceptibility pattern.
Salehi M, Ahmadikia K, Mahmoudi S, Kalantari S, Jamalimoghadamsiahkali S, Izadi A, Kord M, Dehghan Manshadi SA, Seifi A, Ghiasvand F, Khajavirad N, Ebrahimi S, Koohfar A, Boekhout T, Khodavaisy S. Salehi M, et al. Among authors: khajavirad n. Mycoses. 2020 Aug;63(8):771-778. doi: 10.1111/myc.13137. Epub 2020 Jul 23. Mycoses. 2020. PMID: 32609906 Free PMC article.
Intravenous methylprednisolone pulse as a treatment for hospitalised severe COVID-19 patients: results from a randomised controlled clinical trial.
Edalatifard M, Akhtari M, Salehi M, Naderi Z, Jamshidi A, Mostafaei S, Najafizadeh SR, Farhadi E, Jalili N, Esfahani M, Rahimi B, Kazemzadeh H, Mahmoodi Aliabadi M, Ghazanfari T, Sattarian M, Ebrahimi Louyeh H, Raeeskarami SR, Jamalimoghadamsiahkali S, Khajavirad N, Mahmoudi M, Rostamian A. Edalatifard M, et al. Among authors: khajavirad n. Eur Respir J. 2020 Dec 24;56(6):2002808. doi: 10.1183/13993003.02808-2020. Print 2020 Dec. Eur Respir J. 2020. PMID: 32943404 Free PMC article. Clinical Trial.
Clinical Characteristics and Outcomes of 905 COVID-19 Patients Admitted to Imam Khomeini Hospital Complex in the Capital City of Tehran, Iran.
Allameh SF, Nemati S, Ghalehtaki R, Mohammadnejad E, Aghili SM, Khajavirad N, Beigmohammadi MT, Salehi M, Mirfazaelian H, Edalatifard M, Kazemizadeh H, Dehghan Manshadi SA, Hasannezhad M, Amoozadeh L, Radnia M, Khatami SR, Nahvijou A, Seyyedsalehi MS, Rashidian L, Ayoobi Yazdi N, Nasiri Toosi M, Sadeghniiat-Haghighi K, Jafarian A, Yunesian M, Zendehdel K. Allameh SF, et al. Among authors: khajavirad n. Arch Iran Med. 2020 Nov 1;23(11):766-775. doi: 10.34172/aim.2020.102. Arch Iran Med. 2020. PMID: 33220695 Free article.
Interpretation of Hematological, Biochemical, and Immunological Findings of COVID-19 Disease: Biomarkers Associated with Severity and Mortality.
Ghazanfari T, Salehi MR, Namaki S, Arabkheradmand J, Rostamian A, Rajabnia Chenary M, Ghaffarpour S, Kaboudanian Ardestani S, Edalatifard M, Naghizadeh MM, Mohammadi S, Mahloujirad M, Izadi A, Ghanaati H, Beigmohammadi MT, Vodjgani M, Mohammad Shirazi B, Mirsharif ES, Abdollahi A, Mohammadi M, Emadi Kouchak H, Dehghan Manshadi SA, Zamani MS, Mahmoodi Aliabadi M, Jamali D, Khajavirad N, Mohseni Majd AM, Nasiri Z, Faghihzadeh S. Ghazanfari T, et al. Among authors: khajavirad n. Iran J Allergy Asthma Immunol. 2021 Feb 11;20(1):46-66. doi: 10.18502/ijaai.v20i1.5412. Iran J Allergy Asthma Immunol. 2021. PMID: 33639632 Free article.
Evaluation of the effect of sofosbuvir and daclatasvir in hospitalized COVID-19 patients: a randomized double-blind clinical trial (DISCOVER).
Mobarak S, Salasi M, Hormati A, Khodadadi J, Ziaee M, Abedi F, Ebrahimzadeh A, Azarkar Z, Mansour-Ghanaei F, Joukar F, Yeganeh S, Yaghubi Kalurazi T, Naghipour M, Mehrabi Z, Bahadori AR, Yaghoubi S, Moslemi R, Abbaspour Kasgari H, Fakheri H, Moghimi M, Shabani AM, Nekoukar Z, Babamahmoodi F, Davoudi Badabi AR, Davoodi L, Hassaniazad M, Barahimi E, Tousi A, Sadeghi A, Hosamirudsari H, Ali Asgari A, Abdollahi M, Anushiravani A, Shabani M, Shokouhi S, Khajavirad N, Salehi M, Dehghan Manshadi SA, Mousavi H, Zolfaghari F, Azimi E, Zeinali A, Akbarpour E, Merat D, Eslami G, Mousaviasl S, Sayar S, Radmanesh E, Ebrahimzadeh M, Arizavi Z, Jelvay S, Salmanzadeh S, Esmaeilian H, Mobarak M, Karimi J, Poormontaseri Z, Hasooni Bahrini N, Bonyadi A, Dehghani F, Mirzaei H, Noori Jangi M, Pourmasoomi H, Rezaie Keikhaie L, Afshari M, Nateghi Baygi A, Nateghi Baygi H, Levi J, McCann K, Wentzel H, Simmons B, Hill A, Merat S. Mobarak S, et al. Among authors: khajavirad n. J Antimicrob Chemother. 2022 Feb 23;77(3):758-766. doi: 10.1093/jac/dkab433. J Antimicrob Chemother. 2022. PMID: 34849957 Free PMC article. Clinical Trial.
Inflawell® improves neutrophil-to-lymphocyte ratio and shortens hospitalization in patients with moderate COVID-19, in a randomized double-blind placebo-controlled clinical trial.
Barzin Tond S, Balenci L, Khajavirad N, Salehi M, Tafakhori A, Shahmohammadi MR, Ghiasvand F, Jafari S, Abolghasemi S, Mokhtari F, Mahmoodi Baram S, Zarei T, Kazemi D, Mohammadnejad E, Shah-Hosseini A, Haghbin Toutounchi A, Fallah S, Riazi A, Karima S. Barzin Tond S, et al. Among authors: khajavirad n. Inflammopharmacology. 2022 Apr;30(2):465-475. doi: 10.1007/s10787-022-00928-w. Epub 2022 Feb 24. Inflammopharmacology. 2022. PMID: 35201518 Free PMC article. Clinical Trial.
22 results